Iron Chelation as Therapy for HIV and Mycobacterium tuberculosis Co-Infection Under Conditions of Iron Overload

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|12|16|1943-1947

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.12, Iss.16, 2006-06, pp. : 1943-1947

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Tuberculosis and HIV Co-Infection: A Practical Therapeutic Approach

By Breen Ronan A.M.   Swaden Leonie   Ballinger Jayne   Lipman Marc C.I.  

Drugs, Vol. 66, Iss. 18, 2006-01 ,pp. : 2299-2308

Adis International

Access to resources Recommend Favorite

Tuberculosis and HIV Co-Infection: Screening and Treatment Strategies

By Venkatesh Kartik K.  

Drugs, Vol. 71, Iss. 9, 2011-06 ,pp. : 1133-1152

Adis International

Access to resources Recommend Favorite

The Role of Iron Chelation in Cancer Therapy

By  

Current Medicinal Chemistry, Vol. 10, Iss. 12, 2003-06 ,pp. : 1021-1034

Bentham Science Publishers

Access to resources Recommend Favorite

Long-Term Chelation Therapy with Deferasirox: Effects on Cardiac Iron Overload Measured by T2* MRI

By >   Borsellino Zelia   Cuccia Liana   >   Gagliardotto Francesco   Tarantino Rossana  

Clinical Drug Investigation, Vol. 30, Iss. 4, 2010-04 ,pp. : 267-273

Adis International

Access to resources Recommend Favorite

Use chelation therapy to reduce iron overload and improve survival in patients with myelodysplastic syndromes

By  

Drugs & Therapy Perspectives, Vol. 27, Iss. 9, 2011-09 ,pp. : 14-17

Adis International

Access to resources Recommend Favorite